Gsk (GSK) Common Equity (2009 - 2026)
Gsk (GSK) recorded Common Equity of $23.05 billion in the quarter ended Jun 30, 2026, up 20.4% from $19.15 billion a year earlier but down 1.9% from the prior quarter.
Gsk (GSK) Common Equity (2009 - 2026) Analysis & Trends
As of Dec 31, 2025, Gsk reported Common Equity of $21.04 billion, up 25.8% from the prior year.
- Annual Common Equity has increased for three straight years, though with a five-year compound annual growth rate of -4.7% (years ended Dec 2020 to Dec 2025).
- Across earlier years, Common Equity came in at $16.73 billion in the year ended Dec 31, 2024 (+5.1%), $15.91 billion in the year ended Dec 31, 2023 (+27.4%), $12.49 billion in the year ended Dec 31, 2022 (-57.4%) and $29.36 billion in the year ended Dec 31, 2021 (+9.9%).
- Quarterly Common Equity has ranged from $10.27 billion in the quarter ended Sep 30, 2022 to $36.03 billion in the quarter ended Mar 31, 2022 over the past five years.
- On a year-over-year basis, Common Equity has increased for 12 consecutive quarters, with growth averaging 16.6% over the last eight quarters.
- Peak year-over-year performance for Common Equity in the last five years was growth of 55.6% in the quarter ended Sep 30, 2023, against a decline of 65.7% in the quarter ended Sep 30, 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $23.49 billion (quarter ended Mar 31, 2026), $21.22 billion (quarter ended Dec 31, 2025) and $21.26 billion (quarter ended Sep 30, 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,109.58 Bn | 1,078.16 Bn | 19.71 Bn | 33.88 Bn |
| 2 | Johnson & Johnson | 630.16 Bn | 548.69 Bn | 17.26 Bn | 84.97 Bn |
| 3 | AbbVie | 488.57 Bn | 461.73 Bn | 12.70 Bn | -5.94 Bn |
| 4 | Merck | 359.15 Bn | 313.58 Bn | 12.21 Bn | 41.98 Bn |
| 5 | Novartis Ag | 274.32 Bn | 238.71 Bn | 11.24 Bn | 41.95 Bn |
| 6 | Astrazeneca | 246.73 Bn | 220.50 Bn | 12.86 Bn | 50.37 Bn |
| 7 | Amgen | 224.28 Bn | 179.68 Bn | 7.24 Bn | 11.69 Bn |
| 8 | Gilead Sciences | 187.60 Bn | 161.71 Bn | 6.22 Bn | 11.83 Bn |
| 9 | Pfizer | 161.13 Bn | 108.08 Bn | 10.94 Bn | 85.49 Bn |
| 10 | Gsk | 100.33 Bn | 81.91 Bn | 8.24 Bn | 23.05 Bn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 23.05 Bn |
| Mar 31, 2026 | 23.49 Bn |
| Dec 31, 2025 | 21.22 Bn |
| Sep 30, 2025 | 21.26 Bn |
| Jun 30, 2025 | 19.15 Bn |
| Mar 31, 2025 | 17.20 Bn |
| Dec 31, 2024 | 16.80 Bn |
| Sep 30, 2024 | 17.48 Bn |
| Jun 30, 2024 | 17.38 Bn |
| Mar 31, 2024 | 16.78 Bn |
| Dec 31, 2023 | 15.88 Bn |
| Sep 30, 2023 | 15.98 Bn |
| Jun 30, 2023 | 15.22 Bn |
| Mar 31, 2023 | 13.75 Bn |
| Dec 31, 2022 | 11.84 Bn |
| Sep 30, 2022 | 10.27 Bn |
| Jun 30, 2022 | 28.51 Bn |
| Mar 31, 2022 | 36.03 Bn |
| Dec 31, 2021 | 28.77 Bn |
| Sep 30, 2021 | 29.98 Bn |
Gsk Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=GSK&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "GSK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=GSK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();